With this observation, the feedback regulation of S6K to AKT has attracted extensive attention, which may account for a better exploration of the underlying mechanism of rapamycin-induced drug resistance in cancer therapies (Fig. 5A). The gene discussed is RPS6KB1; the disease is cancer.